Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier Proteins | 3 | 2009 | 101 | 0.710 |
Why?
|
| Nuclear Proteins | 3 | 2009 | 84 | 0.710 |
Why?
|
| Lymphatic Vessels | 2 | 2022 | 9 | 0.680 |
Why?
|
| Dependovirus | 3 | 2014 | 37 | 0.500 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 18 | 0.480 |
Why?
|
| Endothelial Cells | 1 | 2014 | 65 | 0.460 |
Why?
|
| Virus Integration | 2 | 2011 | 9 | 0.410 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 275 | 0.390 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2011 | 5 | 0.390 |
Why?
|
| Genome, Viral | 1 | 2011 | 13 | 0.380 |
Why?
|
| Viral Proteins | 1 | 2011 | 24 | 0.380 |
Why?
|
| Cell Nucleolus | 1 | 2009 | 1 | 0.340 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2009 | 1 | 0.340 |
Why?
|
| Telomerase | 1 | 2009 | 10 | 0.340 |
Why?
|
| RNA Precursors | 1 | 2008 | 1 | 0.330 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2008 | 1 | 0.330 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 3 | 0.330 |
Why?
|
| Ribosomes | 1 | 2008 | 3 | 0.330 |
Why?
|
| Cell Cycle | 1 | 2008 | 38 | 0.320 |
Why?
|
| HeLa Cells | 4 | 2011 | 52 | 0.280 |
Why?
|
| Arachnoid | 2 | 2017 | 11 | 0.280 |
Why?
|
| Immunoprecipitation | 3 | 2011 | 23 | 0.250 |
Why?
|
| Indigo Carmine | 1 | 2022 | 1 | 0.210 |
Why?
|
| GTP-Binding Proteins | 3 | 2009 | 11 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2011 | 91 | 0.180 |
Why?
|
| Rats | 3 | 2022 | 873 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2011 | 178 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2017 | 468 | 0.170 |
Why?
|
| Animals | 7 | 2022 | 4722 | 0.160 |
Why?
|
| Genetic Vectors | 3 | 2014 | 63 | 0.150 |
Why?
|
| Biliverdine | 1 | 2017 | 1 | 0.140 |
Why?
|
| Bilirubin | 1 | 2017 | 7 | 0.140 |
Why?
|
| Biological Transport, Active | 1 | 2017 | 18 | 0.140 |
Why?
|
| Erythrocytes | 1 | 2017 | 21 | 0.140 |
Why?
|
| Blood | 1 | 2017 | 25 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 44 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 29 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2016 | 93 | 0.140 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 68 | 0.130 |
Why?
|
| Retroviridae | 1 | 2014 | 6 | 0.120 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2014 | 9 | 0.120 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 18 | 0.120 |
Why?
|
| Iduronidase | 1 | 2014 | 1 | 0.120 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2013 | 7 | 0.110 |
Why?
|
| Hydrocephalus | 1 | 2013 | 27 | 0.110 |
Why?
|
| Apoptosis | 3 | 2022 | 260 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 39 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2014 | 93 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2009 | 24 | 0.100 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2011 | 1 | 0.100 |
Why?
|
| Blotting, Southern | 1 | 2011 | 3 | 0.100 |
Why?
|
| DNA Primers | 1 | 2011 | 53 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 166 | 0.090 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2009 | 1 | 0.090 |
Why?
|
| Muscle Development | 1 | 2009 | 4 | 0.090 |
Why?
|
| Pseudouridine | 1 | 2009 | 1 | 0.090 |
Why?
|
| Chromatography, Thin Layer | 1 | 2009 | 2 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2013 | 539 | 0.080 |
Why?
|
| RNA Interference | 1 | 2009 | 34 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2009 | 75 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 91 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 158 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2009 | 151 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 4 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 6 | 0.080 |
Why?
|
| Proteins | 1 | 2008 | 73 | 0.080 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Succinimides | 1 | 2007 | 2 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2007 | 18 | 0.070 |
Why?
|
| Humans | 6 | 2014 | 30959 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 61 | 0.070 |
Why?
|
| Mannitol | 2 | 2017 | 12 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 370 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2008 | 498 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2022 | 29 | 0.050 |
Why?
|
| Mice | 3 | 2014 | 1683 | 0.050 |
Why?
|
| Brain | 2 | 2022 | 1800 | 0.040 |
Why?
|
| Diuretics, Osmotic | 1 | 2017 | 3 | 0.040 |
Why?
|
| Male | 4 | 2017 | 16425 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2016 | 25 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2016 | 37 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 164 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 75 | 0.030 |
Why?
|
| Collagen | 1 | 2016 | 103 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 305 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 105 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 204 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2014 | 12 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 23 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 62 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 261 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1672 | 0.030 |
Why?
|
| Infant | 1 | 2013 | 578 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 10 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 689 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 637 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 817 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 782 | 0.020 |
Why?
|
| Mitosis | 1 | 2009 | 9 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 28 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 43 | 0.020 |
Why?
|
| Child | 1 | 2013 | 1428 | 0.020 |
Why?
|
| Reoperation | 1 | 2013 | 950 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2007 | 1 | 0.020 |
Why?
|
| Mercaptoethanol | 1 | 2007 | 1 | 0.020 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2007 | 3 | 0.020 |
Why?
|
| Carcinoma, Embryonal | 1 | 2007 | 3 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2007 | 15 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 20 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 2399 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 2060 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 59 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 2586 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 272 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 3658 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 5189 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 8924 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 10192 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 10047 | 0.010 |
Why?
|
| Female | 1 | 2013 | 16965 | 0.010 |
Why?
|